5AM Venture Management, LLC Q4 2025 Filing

Filed February 17, 2026

Portfolio Value

$318.1M

Holdings

21

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (21 positions)

#StockSharesValue% PortfolioType
1
TRDAENTRADA THERAPEUTICS INC
4,056,379$41.7M13.11%
2
CAMPCAMP4 THERAPEUTICS CORP
5,869,091$36.0M11.31%
3
TYRATYRA BIOSCIENCES INC
1,029,298$27.1M8.51%
4
VRDNVIRIDIAN THERAPEUTICS INC
736,595$22.9M7.21%
5
PHVSPHARVARIS N V
797,600$22.1M6.96%
6
ERASERASCA INC
5,405,404$20.1M6.32%
7
EYPTEYEPOINT INC
1,050,000$19.2M6.03%
8
MPLTMAPLIGHT THERAPEUTICS INC
950,011$16.7M5.25%
9
CNTACENTESSA PHARMACEUTICALS PLC
580,945$14.5M4.57%
10
TCE2CELLDEX THERAPEUTICS INC NEW
497,270$13.5M4.25%
11
TECXTECTONIC THERAPEUTIC INC
606,660$12.7M3.98%
12
ELVNENLIVEN THERAPEUTICS INC
772,477$11.9M3.74%
13
ARTVARTIVA BIOTHERAPEUTICS INC
2,353,304$10.1M3.17%
14
SRZNSURROZEN INC
387,500$8.8M2.75%
15
BHVNBIOHAVEN LTD
738,972$8.3M2.62%
16
TARAPROTARA THERAPEUTICS INC
1,369,782$7.3M2.29%
17
GHRSGH RESEARCH PLC
572,665$7.3M2.29%
18
SKYESKYE BIOSCIENCE INC
9,681,763$7.3M2.28%
19
ZNTLZENTALIS PHARMACEUTICALS INC
3,947,913$5.3M1.68%
20
SLNSILENCE THERAPEUTICS PLC
476,200$2.9M0.91%
21
RLYBRALLYBIO CORP
3,630,724$2.5M0.78%